MTOR and metabolic dysfunction-associated steatotic liver disease: The activation of AMPK, well-known physiological inhibitor of the energy-consuming mTOR signaling pathway [13,14,15], is a possible mechanism to explain the inhibition of mTOR/ER stress axis in NAFLD.